Filing Details
- Accession Number:
- 0001209191-21-031177
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-10 13:00:00
- Reporting Period:
- 2021-05-07
- Accepted Time:
- 2021-05-10 12:56:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885978 | U S Physical Therapy Inc | USPH | Services-Health Services (8000) | 760364866 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1519948 | D. Graham Reeve | 1300 W Sam Houston Pkwy S Suite 300 Houston TX 77042 | Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-05-07 | 1,819 | $117.99 | 6,586 | No | 4 | S | Indirect | Reeve Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | Reeve Trust |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 16,035 | Direct |
Footnotes
- Includes 16,035 shares which restrictions lapse as to 1,909 shares on each of July 1 and October 1, 2021; 1,912 shares on January 1, 2022; 1,433 on each of April 1, July 1 and October 1, 2022; 1,448 shares on January 1, 2023; 788 shares on each of April 1, July 1 and October 1, 2023; 794 shares on January 1, 2024; and 350 shares on each of April 1, July 1 and October 1, 2024 and January 1, 2025, if he is employed by the Company on those dates.
- The price reported is a weighted average price ($117.99). The shares were sold in multiple transactions at prices ranging from $117.97 to $118.20 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Billionaire Hedge Funds
